Cadmium-induced up-regulation of aldo-keto reductase 1C3 expression in human nasal septum carcinoma RPMI-2650 cells: Involvement of reactive oxygen species and phosphatidylinositol 3-kinase/Akt

Environmental Toxicology and Pharmacology

Volumn 31, Issue 3, 2011, Pages 469-478

  Lee, Yoon Jin ^a   Lee, Gina J ^b   Baek, Byoung Joon ^c   Heo, Su Hak ^a   Won, Seong Youn ^a   Im, Jae Hyuk ^a   Cho, Moon Kyun ^a   Nam, Hae Seon ^a   Lee, Sang Han ^a  

^a Soonchunhyang University   (South Korea)

^b Poolesville High School   (United States)

^c Soonchunhyang University College of Medicine   (South Korea)

Author keywords

AKR1C3; Cadmium; PI3K Akt; ROS; RPMI 2650 cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLCYSTEINE; ALDO KETO REDUCTASE 1C3; CADMIUM; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDOREDUCTASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CADMIUM POISONING; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NOSE CARCINOMA; NOSE SEPTUM CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ACETYLCYSTEINE; ALCOHOL OXIDOREDUCTASES; ANTIOXIDANTS; BLOTTING, WESTERN; CADMIUM; CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDICATORS AND REAGENTS; NF-E2-RELATED FACTOR 2; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79954644130     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2011.03.006     Document Type: Article

References (45)

1. Badisa V.L., Latinwo L.M., Odewumi C.O., Ikediobi C.O., Badisa R.B., Brooks-Walter A., Lambert A.T., Nwoga J. Cytotoxicity and stress gene microarray analysis in cadmium-exposed CRL-1439 normal rat liver cells. Int. J. Mol. Med. 2008, 22:213-219.
2. Bertin G., Averbeck D. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie 2006, 88:1549-1559.
3. Beyersmann D., Hechtenberg S. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol. Appl. Pharmacol. 1997, 144:247-261.
4. Brama M., Gnessi L., Basciani S., Cerulli N., Politi L., Spera G., Mariani S., Cherubini S., d'Abusco A.S., Scandurra R., Migliaccio S. Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol. Cell. Endocrinol. 2007, 264:102-108.
5. Burczynski M.E., Lin H.K., Penning T.M. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 1999, 59:607-614.
6. Casalino E., Sblano C., Calzaretti G., Landriscina C. Acute cadmium intoxication induces alpha-class glutathione S-transferase protein synthesis and enzyme activity in rat liver. Toxicology 2006, 217:240-245.
7. Chen J., Shaikh Z.A. Activation of Nrf2 by cadmium and its role in protection against cadmium-induced apoptosis in rat kidney cells. Toxicol. Appl. Pharmacol. 2009, 241:81-89.
8. Chen L., Liu L., Luo Y., Huang S. MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis. J. Neurochem. 2008, 105:251-261.
9. Chen Z.H., Yoshida Y., Saito Y., Niki E. Adaptation to hydrogen peroxide enhances PC12 cell tolerance against oxidative damage. Neurosci. Lett. 2005, 383:256-259.
10. Chow K.C., Lu M.P., Wu M.T. Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma. J. Dermatol. Sci. 2006, 41:205-212.
11. Desmond J.C., Mountford J.C., Drayson M.T., Walker E.A., Hewison M., Ride J.P., Luong Q.T., Hayden R.E., Vanin E.F., Bunce C.M. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res. 2003, 63:505-512.
12. Ellis E.M. Reactive carbonyls and oxidative stress: potential for therapeutic intervention. Pharmacol. Ther. 2007, 115:13-24.
13. Gavelová M., Hladíková J., Vildová L., Novotná R., Vondrácek J., Krcmár P., Machala M., Skálová L. Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells. Chem. Biol. Interact. 2008, 176:9-18.
14. Gupta A., Rosenberger S.F., Bowden G.T. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis 1999, 20:2063-2073.
15. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
16. Jarrett S.G., Boulton M.E. Antioxidant up-regulation and increased nuclear DNA protection play key roles in adaptation to oxidative stress in epithelial cells. Free Radic. Biol. Med. 2005, 38:1382-1391.
17. Jin Y., Penning T.M. Review. Aldo-keto reductases and bioactivation/detoxication. Annu. Rev. Pharmacol. Toxicol. 2007, 47:263-292.
18. Jurczuk M., Brzóska M.M., Moniuszko-Jakoniuk J., Gałazyn-Sidorczuk M., Kulikowska-Karpińska E. Antioxidant enzymes activity and lipid peroxidation in liver and kidney of rats exposed to cadmium and ethanol. Food Chem. Toxicol. 2004, 42:429-438.
19. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
20. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 2006, 26:221-229.
21. Klotz L.O., Pellieux C., Briviba K., Pierlot C., Aubry J.M., Sies H. Mitogen-activated protein kinase (p38-, JNK-, ERK-) activation pattern induced by extracellular and intracellular singlet oxygen and UVA. Eur. J. Biochem. 1999, 260:917-922.
22. Lee S.H. Differential gene expression in nickel(II)-treated normal rat kidney cells. Res. Commun. Mol. Pathol. Pharmacol. 2006, 119:77-87.
23. López E., Arce C., Oset-Gasque M.J., Cañadas S., González M.P. Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic. Biol. Med. 2006, 40:940-951.
24. Marín Y.E., Seiberg M., Lin C.B. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival. Exp. Dermatol. 2009, 18:611-618.
25. Matsunaga T., Arakaki M., Kamiya T., Endo S., El-Kabbani O., Hara A. Involvement of an aldo-keto reductase (AKR1C3) in redox cycling of 9,10-phenanthrenequinone leading to apoptosis in human endothelial cells. Chem. Biol. Interact. 2009, 181:52-60.
26. Merkle H.P., Ditzinger G., Lang S.R., Peter H., Schmidt M.C. In vitro cell models to study nasal mucosal permeability and metabolism. Adv. Drug Deliv. Rev. 1998, 29:51-79.
27. Min Y.K., Lee J.E., Chung K.C. Zinc induces cell death in immortalized embryonic hippocampal cells via activation of Akt-GSK-3beta signaling. Exp. Cell Res. 2007, 313:312-321.
28. Moll R., Krepler R., Franke W.W. Complex cytokeratin polypeptide patterns observed in certain human carcinomas. Differentiation 1983, 23:256-269.
29. Nigam D., Shukla G.S., Agarwal A.K. Glutathione depletion and oxidative damage in mitochondria following exposure to cadmium in rat liver and kidney. Toxicol. Lett. 1999, 106:151-157.
30. Novotna R., Wsol V., Xiong G., Maser E. Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3. Toxicol. Lett. 2008, 181:1-6.
31. Ochi T., Ohsawa M. Participation of active oxygen species in the induction of chromosomal aberrations by cadmium chloride in cultured Chinese hamster cells. Mutat. Res. 1985, 143:137-142.
32. Othumpangat S., Kashon M., Joseph P. Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride. J. Biol. Chem. 2005, 280:25162-25169.
33. Palackal N.T., Lee S.H., Harvey R.G., Blair I.A., Penning T.M. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J. Biol. Chem. 2002, 277:24799-24808.
34. Pan J., Chang Q., Wang X., Son Y., Zhang Z., Chen G., Luo J., Bi Y., Chen F., Shi X. Reactive oxygen species-activated Akt/ASK1/p38 signaling pathway in nickel compound-induced apoptosis in BEAS 2B cells. Chem. Res. Toxicol. 2010, 23:568-577.
35. Pathak N., Khandelwal S. Influence of cadmium on murine thymocytes: potentiation of apoptosis and oxidative stress. Toxicol. Lett. 2006, 165:121-132.
36. Penning T.M., Jin Y., Steckelbroeck S., Lanisnik Rizner T., Lewis M. Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins. Mol. Cell. Endocrinol. 2004, 215:63-72.
37. Shih C.M., Ko W.C., Wu J.S., Wei Y.H., Wang L.F., Chang E.E., Lo T.Y., Cheng H.H., Chen C.T. Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts. J. Cell. Biochem. 2004, 91:384-397.
38. Stewart D., Killeen E., Naquin R., Alam S., Alam J. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J. Biol. Chem. 2003, 278:2396-2402.
39. Thévenod F. Cadmium and cellular signaling cascades: to be or not to be?. Toxicol. Appl. Pharmacol. 2009, 238:221-239.
40. Thijssen S., Cuypers A., Maringwa J., Smeets K., Horemans N., Lambrichts I., Van Kerkhove E. Low cadmium exposure triggers a biphasic oxidative stress response in mice kidneys. Toxicology 2007, 236:29-41.
41. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., Griendling K.K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 1999, 274:22699-22704.
42. Wang S., Yang Q., Fung K.M., Lin H.K. AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells. Mol. Cell. Endocrinol. 2008, 289:60-66.
43. Wang X.J., Hayes J.D., Wolf C.R. Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of Nrf2 by cancer chemotherapeutic agents. Cancer Res. 2006, 66:10983-10994.
44. Wätjen W., Beyersmann D. Cadmium-induced apoptosis in C6 glioma cells: influence of oxidative stress. Biometals 2004, 17:65-78.
45. Wengst A., Reichl S. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies. Eur. J. Pharm. Biopharm. 2010, 74:290-297.